speb/financial-data huggingface dataset:
CRCT cash_flow (annual, 2025-12-31) — Operating Gains Losses: -1077000.00
CRCT cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -350000.00
CRCT income_statement (annual, 2025-12-31) — Operating Income: 96033000.00
CRCT income_statement (quarterly, 2025-12-31) — Operating Income: 13936000.00
CRCT income_statement (annual, 2025-12-31) — Operating Revenue: 708780000.00
CRCT income_statement (quarterly, 2025-12-31) — Operating Revenue: 203597000.00
CRCT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 211336284.00
CRCT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 211336284.00
CRCT balance_sheet (annual, 2025-12-31) — Other Current Assets: 29266000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 29266000.00
CRCT balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 166000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 166000.00
CRCT income_statement (annual, 2025-12-31) — Other Gand A: 68464000.00
CRCT income_statement (quarterly, 2025-12-31) — Other Gand A: 15891000.00
CRCT income_statement (annual, 2025-12-31) — Other Income Expense: 1038000.00
CRCT income_statement (quarterly, 2025-12-31) — Other Income Expense: -26000.00
CRCT cash_flow (annual, 2025-12-31) — Other Non Cash Items: 2746000.00
CRCT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 834000.00
CRCT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 16865000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 16865000.00
CRCT balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 5280000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 5280000.00
CRCT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1038000.00
CRCT income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -26000.00
CRCT balance_sheet (annual, 2025-12-31) — Other Properties: 28877000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Other Properties: 28877000.00
CRCT balance_sheet (annual, 2025-12-31) — Other Receivables: 11614000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Other Receivables: 11614000.00
CRCT balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 19434000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 19434000.00
CRCT balance_sheet (annual, 2025-12-31) — Payables: 95914000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Payables: 95914000.00
CRCT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 167060000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 167060000.00
CRCT balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CRCT balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CRCT income_statement (annual, 2025-12-31) — Pretax Income: 107893000.00
CRCT income_statement (quarterly, 2025-12-31) — Pretax Income: 15798000.00
CRCT cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CRCT balance_sheet (annual, 2025-12-31) — Properties: 0.00
CRCT balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CRCT cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -19706000.00
CRCT cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: -3760000.00
CRCT cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
CRCT cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
CRCT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -24417000.00
CRCT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -7234000.00
CRCT balance_sheet (annual, 2025-12-31) — Receivables: 92011000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Receivables: 92011000.00
CRCT balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -1728000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -1728000.00
CRCT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 318349000.00
CRCT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 107149000.00
CRCT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 24439000.00
CRCT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 6303000.00
CRCT cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -24748000.00
CRCT cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -5654000.00
CRCT income_statement (annual, 2025-12-31) — Research And Development: 66522000.00
CRCT income_statement (quarterly, 2025-12-31) — Research And Development: 17238000.00
CRCT balance_sheet (annual, 2025-12-31) — Retained Earnings: 3960000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 3960000.00
CRCT cash_flow (annual, 2025-12-31) — Sale Of Investment: 85074000.00
CRCT cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
CRCT income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 159412000.00
CRCT income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 49383000.00
CRCT income_statement (annual, 2025-12-31) — Selling General And Administration: 227876000.00
CRCT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 65274000.00
CRCT balance_sheet (annual, 2025-12-31) — Share Issued: 211336284.00
CRCT balance_sheet (quarterly, 2025-12-31) — Share Issued: 211336284.00
CRCT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 34791000.00
CRCT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 7269000.00
CRCT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 343561000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 343561000.00
CRCT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 343561000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 343561000.00
CRCT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRCT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRCT income_statement (annual, 2025-12-31) — Tax Provision: 31188000.00
CRCT income_statement (quarterly, 2025-12-31) — Tax Provision: 8007000.00
CRCT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.29
CRCT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CRCT balance_sheet (annual, 2025-12-31) — Total Assets: 580806000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Total Assets: 580806000.00
CRCT balance_sheet (annual, 2025-12-31) — Total Capitalization: 343561000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 343561000.00
CRCT balance_sheet (annual, 2025-12-31) — Total Debt: 11624000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Total Debt: 11624000.00
CRCT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 343561000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 343561000.00
CRCT income_statement (annual, 2025-12-31) — Total Expenses: 612747000.00
CRCT income_statement (quarterly, 2025-12-31) — Total Expenses: 189661000.00
CRCT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 237245000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 237245000.00
CRCT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 81215000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 81215000.00
CRCT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 16170000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 16170000.00
CRCT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 96033000.00
CRCT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 13936000.00
CRCT balance_sheet (annual, 2025-12-31) — Working Capital: 278516000.00
CRCT balance_sheet (quarterly, 2025-12-31) — Working Capital: 278516000.00
CRCT income_statement (quarterly, 2026-03-31) — +Operating Expense: 69812000.00
CRCT income_statement (quarterly, 2026-03-31) — +Total Revenue: 159471000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 57187000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 67713000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 329693000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -1800000.00
CRCT cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 57000.00
CRCT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 210524057.00
CRCT income_statement (quarterly, 2026-03-31) — Basic EPS: 0.10
CRCT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 256216000.00
CRCT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -9130000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 10695000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 210000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 236499000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 255674000.00
CRCT cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -21157000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 43069000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Cash Financial: 193430000.00
CRCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -37389000.00
CRCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -9130000.00
CRCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 26853000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -14093000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -15918000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Inventory: 920000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 40000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -930000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 4160000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Payable: -14093000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -30011000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -3047000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Receivables: 23642000.00
CRCT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -5226000.00
CRCT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 23642000.00
CRCT cash_flow (quarterly, 2026-03-31) — Changes In Cash: -19666000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Common Stock: 210000.00
CRCT cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -21157000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 357491000.00
CRCT cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -12261000.00
CRCT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 66773000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 54384000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Current Assets: 461931000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3577000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3577000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 54709000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 54709000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 169857000.00
CRCT cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -360000.00
CRCT cash_flow (quarterly, 2026-03-31) — Deferred Tax: -360000.00
CRCT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 5613000.00
CRCT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 5613000.00
CRCT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 212547918.00
CRCT income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.10
CRCT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 20318000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 0.00
CRCT income_statement (quarterly, 2026-03-31) — EBIT: 25165000.00
CRCT income_statement (quarterly, 2026-03-31) — EBITDA: 30778000.00
CRCT cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -51000.00
CRCT cash_flow (quarterly, 2026-03-31) — End Cash Position: 236499000.00
CRCT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -37389000.00
CRCT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 17723000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 107000.00
CRCT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 16883000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 69513000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 54195000.00
CRCT income_statement (quarterly, 2026-03-31) — Gross Profit: 92698000.00
CRCT income_statement (quarterly, 2026-03-31) — Interest Expense: 80000.00
CRCT income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 80000.00
CRCT income_statement (quarterly, 2026-03-31) — Interest Income: 2224000.00
CRCT income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 2224000.00
CRCT cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 305000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Inventory: 106038000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 357491000.00
CRCT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -9130000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 7118000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7118000.00
CRCT cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -12261000.00
CRCT cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 581000.00
CRCT income_statement (quarterly, 2026-03-31) — Net Income: 20318000.00
CRCT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 20318000.00
CRCT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 20318000.00
CRCT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 20318000.00
CRCT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 20318000.00
CRCT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 20318000.00
CRCT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 20318000.00
CRCT income_statement (quarterly, 2026-03-31) — Net Interest Income: 2144000.00
CRCT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 2144000.00
CRCT cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -3971000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Net PPE: 54195000.00
CRCT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -9130000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 357491000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 13575000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 2733000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 2733000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 13575000.00
CRCT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 30778000.00
CRCT income_statement (quarterly, 2026-03-31) — Normalized Income: 20318000.00
CRCT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 26853000.00
CRCT cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 581000.00
CRCT income_statement (quarterly, 2026-03-31) — Operating Income: 22886000.00
CRCT income_statement (quarterly, 2026-03-31) — Operating Revenue: 159471000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 209897286.00
CRCT balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 32506000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 107000.00
CRCT income_statement (quarterly, 2026-03-31) — Other Gand A: 16883000.00
CRCT income_statement (quarterly, 2026-03-31) — Other Income Expense: 55000.00
CRCT cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 845000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 14063000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 6565000.00
CRCT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 55000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Other Properties: 54195000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 19175000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Payables: 57187000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 111571000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CRCT income_statement (quarterly, 2026-03-31) — Pretax Income: 25085000.00
CRCT cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -1437000.00
CRCT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -9130000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Receivables: 67713000.00
CRCT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 66773000.00
CRCT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5613000.00
CRCT cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -12261000.00
CRCT income_statement (quarterly, 2026-03-31) — Research And Development: 16602000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 27481000.00
CRCT income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 36327000.00
CRCT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 53210000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Share Issued: 209897286.00
CRCT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 6462000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 357491000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 357491000.00
CRCT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CRCT income_statement (quarterly, 2026-03-31) — Tax Provision: 4767000.00
CRCT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.19
CRCT balance_sheet (quarterly, 2026-03-31) — Total Assets: 543764000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 357491000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Total Debt: 10695000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 357491000.00
CRCT income_statement (quarterly, 2026-03-31) — Total Expenses: 136585000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 186273000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 81833000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 16416000.00
CRCT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 22886000.00
CRCT balance_sheet (quarterly, 2026-03-31) — Working Capital: 292074000.00
CRD.A cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
CRD.A balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 32053000.00
CRD.A cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
CRD.A income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
CRD.A income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
CRD.A cash_flow (annual, 2021-12-31) — Net Other Investing Changes: 6526000.00
CRD.A balance_sheet (annual, 2021-12-31) — Prepaid Assets: 34576000.00
CRD.A cash_flow (annual, 2021-12-31) — Purchase Of Business: -46398000.00
CRD.A cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
CRD.A income_statement (annual, 2021-12-31) — Total Other Finance Cost: 6559000.00
CRD.A income_statement (annual, 2022-12-31) — +Operating Expense: 255750000.00
CRD.A income_statement (annual, 2022-12-31) — +Total Revenue: 1231226000.00
CRD.A balance_sheet (annual, 2022-12-31) — Accounts Payable: 50847000.00
CRD.A balance_sheet (annual, 2022-12-31) — Accounts Receivable: 141106000.00
CRD.A balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -77722000.00
CRD.A balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 78158000.00
CRD.A balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -9322000.00
CRD.A cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 36808000.00
CRD.A income_statement (annual, 2022-12-31) — Basic Average Shares: 49472973.00
CRD.A income_statement (annual, 2022-12-31) — Basic EPS: -0.37
CRD.A cash_flow (annual, 2022-12-31) — Beginning Cash Position: 53689000.00
CRD.A balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 29604000.00
CRD.A cash_flow (annual, 2022-12-31) — Capital Expenditure: -34599000.00
CRD.A cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -27761000.00
CRD.A balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 107792000.00
CRD.A balance_sheet (annual, 2022-12-31) — Capital Stock: 48612000.00
CRD.A balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 46007000.00
CRD.A balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 46007000.00
CRD.A cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -11842000.00
CRD.A cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 25940000.00
CRD.A cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -57876000.00
CRD.A cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 27634000.00
CRD.A cash_flow (annual, 2022-12-31) — Change In Account Payable: -5985000.00
CRD.A cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -1366000.00
CRD.A cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -7841000.00
CRD.A cash_flow (annual, 2022-12-31) — Change In Payable: -5985000.00
CRD.A cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -7351000.00
CRD.A cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 9557000.00
CRD.A cash_flow (annual, 2022-12-31) — Change In Receivables: -34856000.00
CRD.A cash_flow (annual, 2022-12-31) — Change In Working Capital: -40491000.00
CRD.A cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -15537000.00
CRD.A cash_flow (annual, 2022-12-31) — Changes In Cash: -4302000.00
CRD.A balance_sheet (annual, 2022-12-31) — Common Stock: 48612000.00
CRD.A cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -11842000.00
CRD.A balance_sheet (annual, 2022-12-31) — Common Stock Equity: 124543000.00
CRD.A cash_flow (annual, 2022-12-31) — Common Stock Payments: -26749000.00
CRD.A income_statement (annual, 2022-12-31) — Cost Of Revenue: 924872000.00
CRD.A balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 56293000.00
CRD.A balance_sheet (annual, 2022-12-31) — Current Assets: 351267000.00
CRD.A balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 22992000.00
CRD.A balance_sheet (annual, 2022-12-31) — Current Debt: 26966000.00
CRD.A balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 49958000.00
CRD.A balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 29282000.00
CRD.A balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 29282000.00
CRD.A balance_sheet (annual, 2022-12-31) — Current Liabilities: 279487000.00
CRD.A cash_flow (annual, 2022-12-31) — Deferred Income Tax: 7397000.00
CRD.A cash_flow (annual, 2022-12-31) — Deferred Tax: 7397000.00
CRD.A cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 36098000.00
CRD.A cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 36098000.00
CRD.A income_statement (annual, 2022-12-31) — Diluted Average Shares: 49472973.00
CRD.A income_statement (annual, 2022-12-31) — Diluted EPS: -0.37
CRD.A income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -18305000.00
CRD.A income_statement (annual, 2022-12-31) — EBIT: 16012000.00
CRD.A income_statement (annual, 2022-12-31) — EBITDA: 52110000.00
CRD.A cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -2742000.00
CRD.A balance_sheet (annual, 2022-12-31) — Employee Benefits: 25914000.00
CRD.A cash_flow (annual, 2022-12-31) — End Cash Position: 46645000.00
CRD.A cash_flow (annual, 2022-12-31) — Financing Cash Flow: 25940000.00
CRD.A cash_flow (annual, 2022-12-31) — Free Cash Flow: -6965000.00
CRD.A cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 0.00
CRD.A cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -1490000.00
CRD.A income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 0.00
CRD.A balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -215321000.00
CRD.A balance_sheet (annual, 2022-12-31) — Goodwill: 76622000.00
CRD.A balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 247637000.00
CRD.A balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 150428000.00
CRD.A balance_sheet (annual, 2022-12-31) — Gross PPE: 198865000.00
CRD.A income_statement (annual, 2022-12-31) — Gross Profit: 306354000.00
CRD.A income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 36808000.00
CRD.A balance_sheet (annual, 2022-12-31) — Income Tax Payable: 1208000.00
CRD.A income_statement (annual, 2022-12-31) — Interest Expense: 10966000.00
CRD.A income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 10966000.00
CRD.A income_statement (annual, 2022-12-31) — Interest Income: 655000.00
CRD.A income_statement (annual, 2022-12-31) — Interest Income Non Operating: 655000.00
CRD.A balance_sheet (annual, 2022-12-31) — Invested Capital: 363147000.00
CRD.A cash_flow (annual, 2022-12-31) — Investing Cash Flow: -57876000.00
CRD.A cash_flow (annual, 2022-12-31) — Issuance Of Debt: 106481000.00
CRD.A balance_sheet (annual, 2022-12-31) — Leases: 29604000.00
CRD.A balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 84800000.00
CRD.A balance_sheet (annual, 2022-12-31) — Long Term Debt: 211638000.00
CRD.A balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 296438000.00
CRD.A cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -59000.00
CRD.A balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 23642000.00
CRD.A balance_sheet (annual, 2022-12-31) — Minority Interest: -1165000.00
CRD.A income_statement (annual, 2022-12-31) — Minority Interests: 227000.00
CRD.A cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -26309000.00
CRD.A cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -26749000.00
CRD.A balance_sheet (annual, 2022-12-31) — Net Debt: 192597000.00
CRD.A income_statement (annual, 2022-12-31) — Net Income: -18305000.00
CRD.A income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -18305000.00
CRD.A income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -18532000.00
CRD.A income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -18305000.00
CRD.A income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -18305000.00
CRD.A cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -18532000.00
CRD.A income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -18532000.00
CRD.A income_statement (annual, 2022-12-31) — Net Interest Income: -10311000.00
CRD.A cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 67397000.00
CRD.A cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -59000.00
CRD.A income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -10311000.00
CRD.A cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -2983000.00
CRD.A balance_sheet (annual, 2022-12-31) — Net PPE: 121143000.00
CRD.A cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -3806000.00
CRD.A cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 67456000.00
CRD.A balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -123094000.00
CRD.A balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 19573000.00
CRD.A balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 24737000.00
CRD.A balance_sheet (annual, 2022-12-31) — Non Current Deferred Revenue: 24737000.00
CRD.A balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 19573000.00
CRD.A balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 25914000.00
CRD.A income_statement (annual, 2022-12-31) — Normalized EBITDA: 88918000.00
CRD.A income_statement (annual, 2022-12-31) — Normalized Income: 10773320.00
CRD.A cash_flow (annual, 2022-12-31) — Operating Cash Flow: 27634000.00
CRD.A cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1490000.00
CRD.A income_statement (annual, 2022-12-31) — Operating Income: 50604000.00
CRD.A income_statement (annual, 2022-12-31) — Operating Revenue: 1189482000.00
CRD.A balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 48612000.00
CRD.A balance_sheet (annual, 2022-12-31) — Other Current Assets: 28782000.00
CRD.A balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 26966000.00
CRD.A balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 12614000.00
CRD.A balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -215321000.00
CRD.A income_statement (annual, 2022-12-31) — Other Income Expense: -35247000.00
CRD.A balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 171015000.00
CRD.A cash_flow (annual, 2022-12-31) — Other Non Cash Items: 2921000.00
CRD.A balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 51888000.00
CRD.A balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 41553000.00
CRD.A income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1561000.00
CRD.A balance_sheet (annual, 2022-12-31) — Other Properties: 145619000.00
CRD.A balance_sheet (annual, 2022-12-31) — Other Receivables: 126274000.00
CRD.A balance_sheet (annual, 2022-12-31) — Payables: 52055000.00
CRD.A balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 108348000.00
CRD.A balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 79285000.00
CRD.A balance_sheet (annual, 2022-12-31) — Prepaid Assets: 28782000.00
CRD.A income_statement (annual, 2022-12-31) — Pretax Income: 5046000.00
CRD.A cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 117000.00
CRD.A balance_sheet (annual, 2022-12-31) — Properties: 0.00
CRD.A cash_flow (annual, 2022-12-31) — Purchase Of Business: -26309000.00
CRD.A cash_flow (annual, 2022-12-31) — Purchase Of PPE: -6838000.00
CRD.A balance_sheet (annual, 2022-12-31) — Receivables: 276478000.00
CRD.A income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 924872000.00
CRD.A income_statement (annual, 2022-12-31) — Reconciled Depreciation: 36098000.00
CRD.A cash_flow (annual, 2022-12-31) — Repayment Of Debt: -39084000.00
CRD.A cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -26749000.00
CRD.A income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
CRD.A balance_sheet (annual, 2022-12-31) — Retained Earnings: 213094000.00
CRD.A cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CRD.A cash_flow (annual, 2022-12-31) — Sale Of PPE: 3032000.00
CRD.A income_statement (annual, 2022-12-31) — Selling General And Administration: 255750000.00
CRD.A balance_sheet (annual, 2022-12-31) — Share Issued: 48612000.00
CRD.A cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 106481000.00
CRD.A cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -39025000.00
CRD.A income_statement (annual, 2022-12-31) — Special Income Charges: -36808000.00
CRD.A cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4923000.00
CRD.A balance_sheet (annual, 2022-12-31) — Stockholders Equity: 124543000.00
CRD.A balance_sheet (annual, 2022-12-31) — Tangible Book Value: -123094000.00
CRD.A income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -7729680.00
CRD.A income_statement (annual, 2022-12-31) — Tax Provision: 23578000.00
CRD.A income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CRD.A balance_sheet (annual, 2022-12-31) — Taxes Receivable: 9098000.00
CRD.A balance_sheet (annual, 2022-12-31) — Total Assets: 791507000.00
CRD.A balance_sheet (annual, 2022-12-31) — Total Capitalization: 336181000.00
CRD.A balance_sheet (annual, 2022-12-31) — Total Debt: 346396000.00
CRD.A balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 123378000.00
CRD.A income_statement (annual, 2022-12-31) — Total Expenses: 1180622000.00
CRD.A balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 668129000.00
CRD.A balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 440241000.00
CRD.A balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 388642000.00
CRD.A income_statement (annual, 2022-12-31) — Total Other Finance Cost: 10311000.00
CRD.A balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1208000.00
CRD.A income_statement (annual, 2022-12-31) — Total Unusual Items: -36808000.00
CRD.A income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -36808000.00
CRD.A balance_sheet (annual, 2022-12-31) — Working Capital: 71780000.00
CRD.A income_statement (annual, 2023-12-31) — +Operating Expense: 286506000.00
CRD.A income_statement (annual, 2023-12-31) — +Total Revenue: 1316919000.00
CRD.A balance_sheet (annual, 2023-12-31) — Accounts Payable: 45107000.00
CRD.A balance_sheet (annual, 2023-12-31) — Accounts Receivable: 131362000.00
CRD.A balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -80784000.00
CRD.A balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 82589000.00
CRD.A balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -8599000.00
CRD.A cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
CRD.A income_statement (annual, 2023-12-31) — Basic Average Shares: 48835000.00
CRD.A income_statement (annual, 2023-12-31) — Basic EPS: 0.63
CRD.A cash_flow (annual, 2023-12-31) — Beginning Cash Position: 46645000.00
CRD.A cash_flow (annual, 2023-12-31) — Capital Expenditure: -36596000.00
CRD.A cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -31706000.00
CRD.A balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 102528000.00
CRD.A balance_sheet (annual, 2023-12-31) — Capital Stock: 49080000.00
CRD.A balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 58363000.00
CRD.A balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 58363000.00
CRD.A cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -12701000.00
CRD.A cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -54680000.00
CRD.A cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -36596000.00
CRD.A cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 103790000.00
CRD.A cash_flow (annual, 2023-12-31) — Change In Account Payable: -2822000.00
CRD.A cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 7174000.00
CRD.A cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 18976000.00
CRD.A cash_flow (annual, 2023-12-31) — Change In Payable: -2822000.00
CRD.A cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 4352000.00
CRD.A cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -7077000.00
CRD.A cash_flow (annual, 2023-12-31) — Change In Receivables: 23542000.00
CRD.A cash_flow (annual, 2023-12-31) — Change In Working Capital: 39793000.00
CRD.A cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 11663000.00
CRD.A cash_flow (annual, 2023-12-31) — Changes In Cash: 12514000.00
CRD.A balance_sheet (annual, 2023-12-31) — Common Stock: 49080000.00
CRD.A cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -12701000.00
CRD.A balance_sheet (annual, 2023-12-31) — Common Stock Equity: 141618000.00
CRD.A cash_flow (annual, 2023-12-31) — Common Stock Payments: -2731000.00
CRD.A income_statement (annual, 2023-12-31) — Cost Of Revenue: 957847000.00
CRD.A balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 42271000.00
CRD.A balance_sheet (annual, 2023-12-31) — Current Assets: 369346000.00
CRD.A balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 24437000.00
CRD.A balance_sheet (annual, 2023-12-31) — Current Debt: 14727000.00
CRD.A balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 39164000.00
CRD.A balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 35540000.00
CRD.A balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 35540000.00
CRD.A balance_sheet (annual, 2023-12-31) — Current Liabilities: 299292000.00
CRD.A cash_flow (annual, 2023-12-31) — Deferred Income Tax: -12279000.00
CRD.A cash_flow (annual, 2023-12-31) — Deferred Tax: -12279000.00
CRD.A cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 35742000.00
CRD.A cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 35742000.00
CRD.A income_statement (annual, 2023-12-31) — Diluted Average Shares: 49595000.00
CRD.A income_statement (annual, 2023-12-31) — Diluted EPS: 0.61
CRD.A income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 30609000.00
CRD.A income_statement (annual, 2023-12-31) — EBIT: 67166000.00
CRD.A income_statement (annual, 2023-12-31) — EBITDA: 102908000.00
CRD.A cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 386000.00
CRD.A balance_sheet (annual, 2023-12-31) — Employee Benefits: 24006000.00
CRD.A cash_flow (annual, 2023-12-31) — End Cash Position: 59545000.00
CRD.A cash_flow (annual, 2023-12-31) — Financing Cash Flow: -54680000.00
CRD.A cash_flow (annual, 2023-12-31) — Free Cash Flow: 67194000.00
CRD.A cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 646000.00
CRD.A balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -218615000.00
CRD.A balance_sheet (annual, 2023-12-31) — Goodwill: 76724000.00
CRD.A balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 255280000.00
CRD.A balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 139961000.00
CRD.A balance_sheet (annual, 2023-12-31) — Gross PPE: 192141000.00
CRD.A income_statement (annual, 2023-12-31) — Gross Profit: 359072000.00
CRD.A income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CRD.A cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 16050000.00
CRD.A balance_sheet (annual, 2023-12-31) — Income Tax Payable: 6130000.00
CRD.A income_statement (annual, 2023-12-31) — Interest Expense: 19809000.00
CRD.A income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 19809000.00
CRD.A income_statement (annual, 2023-12-31) — Interest Income: 2773000.00
CRD.A income_statement (annual, 2023-12-31) — Interest Income Non Operating: 2773000.00
CRD.A cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 18914000.00
CRD.A balance_sheet (annual, 2023-12-31) — Invested Capital: 350618000.00
CRD.A cash_flow (annual, 2023-12-31) — Investing Cash Flow: -36596000.00
CRD.A cash_flow (annual, 2023-12-31) — Issuance Of Debt: 37578000.00
CRD.A balance_sheet (annual, 2023-12-31) — Leases: 30663000.00
CRD.A balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 78091000.00
CRD.A balance_sheet (annual, 2023-12-31) — Long Term Debt: 194273000.00
CRD.A balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 272364000.00
CRD.A cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -60000.00
CRD.A balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 21394000.00
CRD.A balance_sheet (annual, 2023-12-31) — Minority Interest: -1787000.00
CRD.A income_statement (annual, 2023-12-31) — Minority Interests: 349000.00
CRD.A cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CRD.A cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -2731000.00
CRD.A balance_sheet (annual, 2023-12-31) — Net Debt: 150637000.00
CRD.A income_statement (annual, 2023-12-31) — Net Income: 30609000.00
CRD.A income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 30609000.00
CRD.A income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 30260000.00
CRD.A income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 30609000.00
CRD.A income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 30609000.00
CRD.A cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 30260000.00
CRD.A income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 30260000.00
CRD.A income_statement (annual, 2023-12-31) — Net Interest Income: -17036000.00
CRD.A cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -31548000.00
CRD.A cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -60000.00
CRD.A income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -17036000.00
CRD.A cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -7289000.00
CRD.A balance_sheet (annual, 2023-12-31) — Net PPE: 111357000.00
CRD.A cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -4890000.00
CRD.A cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -31488000.00
CRD.A balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -113662000.00
CRD.A balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 26247000.00
CRD.A balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 24871000.00
CRD.A balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 24871000.00
CRD.A balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 26247000.00
CRD.A balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 24006000.00
CRD.A income_statement (annual, 2023-12-31) — Normalized EBITDA: 102908000.00
CRD.A income_statement (annual, 2023-12-31) — Normalized Income: 30609000.00
CRD.A cash_flow (annual, 2023-12-31) — Operating Cash Flow: 103790000.00
CRD.A cash_flow (annual, 2023-12-31) — Operating Gains Losses: 646000.00
CRD.A income_statement (annual, 2023-12-31) — Operating Income: 72566000.00
CRD.A income_statement (annual, 2023-12-31) — Operating Revenue: 1267131000.00
CRD.A balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 49080000.00
CRD.A balance_sheet (annual, 2023-12-31) — Other Current Assets: 58168000.00
CRD.A balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 14727000.00
CRD.A balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 33238000.00
CRD.A balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -218615000.00
CRD.A income_statement (annual, 2023-12-31) — Other Income Expense: -8173000.00
CRD.A balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 178556000.00
CRD.A cash_flow (annual, 2023-12-31) — Other Non Cash Items: 4025000.00
CRD.A balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 36969000.00
CRD.A balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 38835000.00
CRD.A income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -8173000.00
CRD.A balance_sheet (annual, 2023-12-31) — Other Properties: 140084000.00
CRD.A balance_sheet (annual, 2023-12-31) — Other Receivables: 116611000.00
CRD.A balance_sheet (annual, 2023-12-31) — Payables: 51237000.00
CRD.A balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 93508000.00
CRD.A balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 97842000.00
CRD.A income_statement (annual, 2023-12-31) — Pretax Income: 47357000.00
CRD.A cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: -411000.00
CRD.A balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRD.A cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CRD.A cash_flow (annual, 2023-12-31) — Purchase Of PPE: -4890000.00
CRD.A balance_sheet (annual, 2023-12-31) — Receivables: 252815000.00
CRD.A income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 957847000.00
CRD.A income_statement (annual, 2023-12-31) — Reconciled Depreciation: 35742000.00
CRD.A cash_flow (annual, 2023-12-31) — Repayment Of Debt: -69126000.00
CRD.A cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -2731000.00
CRD.A income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 0.00
CRD.A balance_sheet (annual, 2023-12-31) — Retained Earnings: 228564000.00
CRD.A cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
CRD.A cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
CRD.A income_statement (annual, 2023-12-31) — Selling General And Administration: 286506000.00
CRD.A balance_sheet (annual, 2023-12-31) — Share Issued: 49080000.00
CRD.A cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 37578000.00
CRD.A cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -69066000.00
CRD.A income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CRD.A cash_flow (annual, 2023-12-31) — Stock Based Compensation: 5603000.00
CRD.A balance_sheet (annual, 2023-12-31) — Stockholders Equity: 141618000.00
CRD.A balance_sheet (annual, 2023-12-31) — Tangible Book Value: -113662000.00
CRD.A income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CRD.A income_statement (annual, 2023-12-31) — Tax Provision: 17097000.00
CRD.A income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.36
CRD.A balance_sheet (annual, 2023-12-31) — Taxes Receivable: 4842000.00
CRD.A balance_sheet (annual, 2023-12-31) — Total Assets: 799199000.00
CRD.A balance_sheet (annual, 2023-12-31) — Total Capitalization: 335891000.00
CRD.A balance_sheet (annual, 2023-12-31) — Total Debt: 311528000.00
CRD.A balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 139831000.00
CRD.A income_statement (annual, 2023-12-31) — Total Expenses: 1244353000.00
CRD.A balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 659368000.00
CRD.A balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 429853000.00
CRD.A balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 360076000.00
CRD.A balance_sheet (annual, 2023-12-31) — Total Tax Payable: 6130000.00
CRD.A income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CRD.A income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CRD.A balance_sheet (annual, 2023-12-31) — Working Capital: 70054000.00
CRD.A income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 74016000.00
CRD.A income_statement (quarterly, 2024-09-30) — Other Gand A: 71526000.00
CRD.A income_statement (quarterly, 2024-09-30) — Salaries And Wages: 2490000.00
CRD.A income_statement (annual, 2024-12-31) — +Operating Expense: 299664000.00
CRD.A income_statement (quarterly, 2024-12-31) — +Operating Expense: 71087000.00
CRD.A income_statement (annual, 2024-12-31) — +Total Revenue: 1340970000.00
CRD.A income_statement (quarterly, 2024-12-31) — +Total Revenue: 358318000.00
CRD.A balance_sheet (annual, 2024-12-31) — Accounts Payable: 50605000.00
CRD.A balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 50605000.00
CRD.A balance_sheet (annual, 2024-12-31) — Accounts Receivable: 142064000.00
CRD.A balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 142064000.00
CRD.A balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -73756000.00
CRD.A balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -73756000.00
CRD.A balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 87118000.00
CRD.A balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 87118000.00
CRD.A balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -8145000.00
CRD.A balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -8145000.00
CRD.A cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00